Status:
COMPLETED
Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Lead Sponsor:
Pfizer
Conditions:
Spondyloarthrosis
Eligibility:
All Genders
18+ years
Brief Summary
This study is to evaluate local data in Iraqi patients with Spondyloarthropathies on Enbrel treatment with regards to efficacy and adherence using data from the Baghdad Teaching Hospital (Rheumatology...
Eligibility Criteria
Inclusion
- Diagnosed SpA patients
- 18 years of age and older.
- Did not receive previous other biological treatments.
- Patients have at least 1 year on Enbrel.
Exclusion
- Had previously used another biological treatments.
- Use of etanercept for less than 1 year duration.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
763 Patients enrolled
Trial Details
Trial ID
NCT04507776
Start Date
September 1 2020
End Date
October 1 2020
Last Update
October 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer
Baghdad, Iraq